Per Venge

Q: What Schools Are Affiliated With Per Venge

Per Venge is affiliated with the following schools: Uppsala University, University of Alberta, University of Gothenburg

Per Venge's AcademicInfluence.com Rankings

Per Venge

Philosophy

#3426

World Rank

#5547

Historical Rank

Logic

#1153

World Rank

#1828

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Per Venge Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Per Venge's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Eosinophilic inflammation in asthma. (1990) (2524)
Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. (2000) (1299)
Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. (1985) (1120)
Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. (2011) (777)
Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. (2008) (706)
N‐Terminal Pro‐Brain Natriuretic Peptide and Other Risk Markers for the Separate Prediction of Mortality and Subsequent Myocardial Infarction in Patients With Unstable Coronary Artery Disease: A Global Utilization of Strategies To Open occluded arteries (GUSTO)‐IV Substudy (2003) (627)
The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies. (2011) (620)
Recommendations for the use of cardiac troponin measurement in acute cardiac care. (2010) (619)
Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial. (2012) (540)
Low-molecular-weight heparin during instability in coronary artery disease (1996) (533)
How to use high-sensitivity cardiac troponins in acute cardiac care (2012) (484)
Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group. (1996) (460)
Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group. (1997) (444)
Mechanism of membrane damage mediated by human eosinophil cationic protein (1986) (406)
Soluble markers of allergic inflammation (1994) (376)
N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation. (2002) (373)
How to use high-sensitivity cardiac troponins in acute cardiac care. (2013) (345)
Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease. Investigators. (1999) (339)
Multicenter analytical evaluation of a high-sensitivity troponin T assay. (2011) (338)
Inflammation and structural changes in the airways of patients with atopic and nonatopic asthma. BHR Group. (2000) (331)
Cytokine‐regulated accumulation of eosinophils in inflammatory disease (2004) (330)
Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage. The effects of antiasthmatic treatment with budesonide or terbutaline. (1990) (307)
Monoclonal antibodies distinguish between storage and secreted forms of eosinophil cationic protein (1984) (305)
Lipocalins as biochemical markers of disease. (2000) (290)
Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. (2012) (288)
Neutrophil gelatinase-associated lipocalin in adult septic patients with and without acute kidney injury (2010) (286)
Troponin I as a Predictor of Coronary Heart Disease and Mortality in 70-Year-Old Men: A Community-Based Cohort Study (2006) (284)
Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy. (2002) (281)
The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients. (1988) (275)
Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy. (2003) (265)
Neutrophil granule proteins in bronchoalveolar lavage fluid from subjects with subclinical emphysema. (1999) (248)
The origin of multiple molecular forms in urine of HNL/NGAL. (2010) (245)
Cationic proteins of human granulocytes. II. Separation of the cationic proteins of the granules of leukemic myeloid cells. (1974) (242)
Growth Differentiation Factor 15 for Risk Stratification and Selection of an Invasive Treatment Strategy in Non–ST-Elevation Acute Coronary Syndrome (2007) (216)
Indirect evidence of bronchial inflammation assessed by titration of inflammatory mediators in BAL fluid of patients with asthma. (1991) (216)
Radioimmunoassay of human eosinophil cationic protein (ECP) by an improved method. Establishment of normal levels in serum and turnover in vivo (1991) (213)
Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study. (2009) (211)
Active participation of eosinophils in patch test reactions to inhalant allergens in patients with atopic dermatitis (1988) (210)
Regulation of granulocyte function by hyaluronic acid. In vitro and in vivo effects on phagocytosis, locomotion, and metabolism. (1980) (207)
Airway inflammation in smokers with nonobstructive and obstructive chronic bronchitis. (1993) (207)
Respiratory symptoms, bronchial responsiveness, and cellular characteristics of induced sputum in elite swimmers (1998) (207)
Stimulation of degranulation from human eosinophils by platelet-activating factor. (1989) (203)
Radioimmunoassay of Human Eosinophil Cationic Protein (1977) (191)
Distinctive cationic proteins of the human eosinophil granule: major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin. (1983) (188)
Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide. The impact of smoking. (1996) (182)
Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass. (1994) (174)
Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ischemia. (2009) (171)
The Gordon phenomenon induced by the eosinophil cationic protein and eosinophil protein X. (1982) (163)
Human eosinophil peroxidase: purification and characterization. (1985) (162)
Clinical performance of three cardiac troponin assays in patients with unstable coronary artery disease (a FRISC II substudy). (2002) (162)
Cationic proteins of human granulocytes. VI. Effects on the complement system and mediation of chemotactic activity. (1975) (159)
Prevalence and pathophysiological mechanisms of elevated cardiac troponin I levels in a population-based sample of elderly subjects. (2008) (159)
Purification and characterization of a human neutrophil lipocalin (HNL) from the secondary granules of human neutrophils. (1994) (157)
Blood eosinophil number and activity in relation to lung function in patients with asthma and with eosinophilia. (1991) (155)
Serum measurements of human neutrophil lipocalin (HNL) discriminate between acute bacterial and viral infections. (1995) (155)
Epithelial injury by human eosinophils. (1988) (153)
Nasal and ocular symptoms, tear film stability and biomarkers in nasal lavage, in relation to building-dampness and building design in hospitals (1999) (151)
Persistent Cardiac Troponin I Elevation in Stabilized Patients After an Episode of Acute Coronary Syndrome Predicts Long-Term Mortality (2007) (149)
Secretion of granule proteins from eosinophils and neutrophils is increased in asthma. (1991) (147)
The prognostic and therapeutic implications of increased troponin T levels and ST depression in unstable coronary artery disease: the FRISC II invasive troponin T electrocardiogram substudy. (2002) (146)
Arginine-rich cationic proteins of human eosinophil granules: comparison of the constituents of eosinophilic and neutrophilic leukocytes. (1977) (146)
Monitoring the allergic inflammation (2004) (142)
Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial. (2003) (142)
Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: a Fragmin and fast Revascularisation during In Stability in Coronary artery disease (FRISC)-II substudy. (2005) (141)
Serum myeloperoxidase and lactoferrin in neutropenia. (2009) (139)
Serum ferritin during infection. A longitudinal study. (2009) (138)
Morphological studies on the killing of schistosomula of Schistosoma mansoni by human eosinophil and neutrophil cationic proteins in vitro (1981) (136)
Albumin, bradykinins, and eosinophil cationic protein on the nasal mucosal surface in patients with hay fever during natural allergen exposure. (1990) (134)
Variations of Blood Eosinophils and Eosinophil Cationic Protein in Serum in Patients with Bronchial Asthma (1978) (132)
Assessment of Cell-Cycle Arrest Biomarkers to Predict Early and Delayed Acute Kidney Injury (2015) (131)
Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypass. A clinical study. (1992) (130)
Mast cells express functional CD30 ligand and are the predominant CD30L‐positive cells in Hodgkin's disease (2001) (128)
Expression of laminins in the airways in various types of asthmatic patients: a morphometric study. (1996) (127)
The effect of immunotherapy on eosinophil accumulation and production of eosinophil chemotactic activity in the lung of subjects with asthma during natural pollen exposure. (1991) (126)
The eosinophil component of the alveolitis in idiopathic pulmonary fibrosis. Signs of eosinophil activation in the lung are related to impaired lung function. (1989) (124)
Attenuation of changes in leukocyte surface markers and complement activation with heparin-coated cardiopulmonary bypass. (1997) (123)
Neutrophil and eosinophil involvement of the small bowel in patients with celiac disease and Crohn's disease: studies on the secretion rate and immunohistochemical localization of granulocyte granule constituents. (1989) (123)
Serum measurements of eosinophil cationic protein (ECP) in bronchial asthma (1993) (121)
Identification of IL-5 and RANTES as the major eosinophil chemoattractants in the asthmatic lung. (1996) (119)
Cardiac troponin I levels measured with a high-sensitive assay increase over time and are strong predictors of mortality in an elderly population. (2013) (118)
Degranulation of eosinophils from pollen-atopic patients with asthma is increased during pollen season. (1992) (117)
Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: a GUSTO-IV substudy. (2006) (117)
Risk stratification in unstable coronary artery disease. Additive value of troponin T determinations and pre-discharge exercise tests. FRISK Study Group. (1997) (116)
Multicenter evaluation of an automated assay for troponin I. (2002) (115)
Relationship between inflammatory cells and structural changes in the lungs of asymptomatic and never smokers: a biopsy study (2003) (114)
Human neutrophil lipocalin is a unique marker of neutrophil inflammation in ulcerative colitis and proctitis (2002) (114)
FRISC score for selection of patients for an early invasive treatment strategy in unstable coronary artery disease (2005) (112)
Enhancement of factor XII dependent reactions by eosinophil cationic protein. (1979) (112)
The new high-sensitivity cardiac troponin T assay improves risk assessment in acute coronary syndromes. (2010) (111)
Indoor air pollutants in schools: nasal patency and biomarkers in nasal lavage (2000) (110)
Increased intraluminal release of eosinophil granule proteins EPO, ECP, EPX, and cytokines in ulcerative colitis and proctitis in segmental perfusion (1999) (108)
Clinical and subclinical intestinal inflammation assessed by the mucosal patch technique: studies of mucosal neutrophil and eosinophil activation in inflammatory bowel diseases and irritable bowel syndrome (2004) (106)
The extracellular deposition of mast cell products is increased in hypertrophic airways smooth muscles in allergic asthma but not in nonallergic asthma (2005) (106)
Eosinophil activation in allergic disease. (1987) (105)
Eosinophil peroxidase produces hypobromous acid in the airways of stable asthmatics. (2002) (104)
Eosinophil cationic protein and myeloperoxidase in nasal secretion as markers of inflammation in allergic rhinitis (1987) (104)
Neutrophil-associated activation markers in healthy smokers relates to a fall in DL(CO) and to emphysematous changes on high resolution CT. (2001) (103)
Human eosinophil cationic proteins (ECP and EPX) and their suppressive effects on lymphocyte proliferation. (1986) (101)
Low molecular weight heparin (dalteparin) as adjuvant treatment of thrombolysis in acute myocardial infarction--a pilot study: biochemical markers in acute coronary syndromes (BIOMACS II). (1999) (99)
Biochemical indicators of cardiac and renal function in a healthy elderly population. (2004) (98)
Bronchial biopsy findings in intermittent or "early" asthma. (1996) (97)
Eosinophil granule proteins in serum after allergen challenge of asthmatic patients and the effects of anti-asthmatic medication. (1988) (97)
Biopsy markers of airway inflammation and remodelling. (2000) (97)
Red Blood Cell Preservation in Protein‐Poor Media: I. Leukocyte Enzymes as a Cause of Hemolysis (1978) (96)
Neutrophils from Term and Preterm Newborn Infants Express the High Affinity Fcγ-Receptor I (CD64) During Bacterial Infections (1999) (95)
Quantitative analysis of the admission electrocardiogram identifies patients with unstable coronary artery disease who benefit the most from early invasive treatment. (2003) (95)
Allergen-induced increase of eosinophil cationic protein in nasal lavage fluid: effect of the glucocorticoid budesonide. (1990) (94)
Serum lysozyme: a potential marker of monocyte/macrophage activity in rheumatoid arthritis. (1999) (94)
Analysis of fluidphase mediators (2002) (93)
Nasal patency and biomarkers in nasal lavage – the significance of air exchange rate and type of ventilation in schools (1998) (92)
Value of cardiac troponin I cutoff concentrations below the 99th percentile for clinical decision-making. (2009) (92)
Proteomic analysis of human cervical-vaginal fluids. (2007) (92)
Nasal Lavage Biomarkers: Effects of Water Damage and Microbial Growth in an Office Building (2001) (91)
Influence of allergen avoidance at high altitude on serum markers of eosinophil activation in children with allergic asthma (1993) (91)
Immunoassays distinguishing between HNL/NGAL released in urine from kidney epithelial cells and neutrophils. (2012) (90)
Purification and characterization of a new cationic protein--eosinophil protein-X (EPX)--from granules of human eosinophils. (1983) (90)
Purification and characterization of eosinophil cationic protein from normal human eosinophils (1988) (89)
The influence of IL-3, IL-5, and GM-CSF on normal human eosinophil and neutrophil C3b-induced degranulation. (1993) (89)
Eosinophil cationic protein alters proteoglycan metabolism in human lung fibroblast cultures. (1992) (88)
Immunotherapy abrogates the generation of eosinophil and neutrophil chemotactic activity during pollen season. (1990) (88)
Centrifugal pump and heparin coating improves cardiopulmonary bypass biocompatibility. (1996) (87)
The effect of salmeterol on the early‐ and late‐phase reaction to bronchial allergen and postchallenge variation in bronchial reactivity, blood eosinophils, serum eosinophil cationic protein, and serum eosinophil protein X (1993) (87)
Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome. (2009) (87)
Cardiac troponin I is associated with severity of myxomatous mitral valve disease, age, and C-reactive protein in dogs. (2010) (87)
Inflammatory cell and epithelial characteristics of perennial allergic and nonallergic rhinitis with a symptom history of 1 to 3 years' duration. (2001) (86)
Cardiac troponin: a critical review of the case for point-of-care testing in the ED. (2012) (86)
Evidence of eosinophil, neutrophil, and mast‐cell mediators in the effusion of OME patients with and without atopy (2000) (85)
Growth-Differentiation Factor-15 for Long-Term Risk Prediction in Patients Stabilized After an Episode of Non–ST-Segment–Elevation Acute Coronary Syndrome (2010) (84)
The development of an assay for human neutrophil lipocalin (HNL)--to be used as a specific marker of neutrophil activity in vivo and vitro. (1994) (82)
Neutrophil and Eosinophil Granulocytes in Bacterial Infection: Sequential Studies of Cellular and Serum Levels of Granule Proteins (1978) (82)
Detection of eosinophil cationic protein (ECP) by an enzyme-linked immunosorbent assay. (1991) (81)
The effect of eosinophils on collagen gel contraction and implications for tissue remodelling (2004) (80)
ST2 and mortality in non-ST-segment elevation acute coronary syndrome. (2010) (80)
Schistosoma mansoni: further studies of the interaction between schistosomula and granulocyte-derived cationic proteins in vitro (1984) (80)
Effects of in vivo administration of G–CSF on neutrophil functions in healthy volunteers (1997) (79)
The antibody configurations of cardiac troponin I assays may determine their clinical performance. (2006) (78)
N-Terminal Pro-Brain Natriuretic Peptide in Relation to Inflammation, Myocardial Necrosis, and the Effect of an Invasive Strategy in Unstable Coronary Artery Disease (2004) (78)
Piecemeal degranulation of peripheral blood eosinophils: a study of allergic subjects during and out of the pollen season. (2000) (76)
New reference values for routine blood samples and human neutrophilic lipocalin during third-trimester pregnancy (2001) (76)
IL-5 and TNF-α Participate in Recruitment of Eosinophils to Intestinal Mucosa in Ulcerative Colitis (2001) (76)
Complement and granulocyte activation in two different types of heparinized extracorporeal circuits. (1995) (76)
Effects of salmeterol on mucosal inflammation in asthma: a placebo-controlled study (2002) (76)
Natriuretic peptides in unstable coronary artery disease. (2004) (75)
Serum levels of granulocyte‐colony stimulating factor (G‐CSF) in bacterial and viral infections, and in atypical pneumonia (1994) (75)
Clinical performance of two highly sensitive cardiac troponin I assays. (2009) (75)
Short- and long-term individual variation in cardiac troponin in patients with stable coronary artery disease. (2013) (75)
N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease. (2003) (74)
Eosinophils in exercise-induced asthma. (1991) (73)
A double-blinded, comparative study of the effects of short preseason specific immunotherapy and topical steroids in patients with allergic rhinoconjunctivitis and asthma. (2001) (72)
Neutrophil CD64 (FcγRI) expression is a specific marker of bacterial infection: A study on the kinetics and the impact of major surgery (2007) (71)
Eosinophils, secretory responsiveness and glucocorticoid‐induced effects on the nasal mucosa during a weak pollen season (1991) (71)
A fasting and vegetarian diet treatment trial on chronic inflammatory disorders. (1983) (71)
Improving long-term risk prediction in patients with acute chest pain: the Global Registry of Acute Coronary Events (GRACE) risk score is enhanced by selected nonnecrosis biomarkers. (2010) (71)
Cardiac troponin-I and risk of heart failure: a community-based cohort study. (2008) (70)
Different airway responsiveness profiles in atopic asthma, nonatopic asthma, and Sjögren's syndrome (2000) (70)
Blood eosinophil numbers and activity during 24 hours: effects of treatment with budesonide and bambuterol. (1992) (70)
Perifolliculitis capitis abscedens et suffodiens (Hoffman). Complete healing associated with oral zinc therapy. (1985) (70)
Human neutrophil lipocalin (HNL) as a diagnostic tool in children with acute infections: a study of the kinetics. (2005) (69)
High-sensitive cardiac troponin, NT-proBNP, hFABP and copeptin levels in relation to glomerular filtration rates and a medical record of cardiovascular disease. (2015) (69)
Reduced granulocyte activation with a heparin-coated device in an in vitro model of cardiopulmonary bypass. (2008) (67)
Effects of serum and cations on the selective release of granular proteins from human netrophils during phagocytosis. (2009) (67)
Ultrastructure of bronchial biopsies from patients with allergic and non-allergic asthma. (2005) (67)
Signs of neutrophil and eosinophil activation in adult respiratory distress syndrome (1984) (67)
Surface characteristics of the U-937 human histiocytic lymphoma cell line: specific changes during inducible morphologic and functional differentiation in vitro. (1981) (67)
The nature and discriminatory value of urinary neutrophil gelatinase-associated lipocalin in critically ill patients at risk of acute kidney injury (2013) (66)
Priming of eosinophil adhesion in patients with birch pollen allergy during pollen season: effect of immunotherapy. (1997) (66)
Will the universal definition of myocardial infarction criteria result in an overdiagnosis of myocardial infarction? (2009) (66)
Early invasive versus non-invasive treatment in patients with non-ST-elevation acute coronary syndrome (FRISC-II): 15 year follow-up of a prospective, randomised, multicentre study (2016) (65)
Eosinophil activation in the lung is related to lung damage in adult respiratory distress syndrome. (1987) (64)
Assays of urine levels of HNL/NGAL in patients undergoing cardiac surgery and the impact of antibody configuration on their clinical performances. (2009) (64)
MOLECULES IN FOCUS. EOSINOPHIL CATIONIC PROTEIN (ECP) (1998) (64)
The value of serum myoglobin determinations in the early diagnosis of acute myocardial infarction. (2009) (63)
Changes in non‐specific nasal reactivity and eosinophil influx and activation after allergen challenge (1990) (62)
NT‐proBNP in unstable coronary artery disease—experiences from the FAST, GUSTO IV and FRISC II trials (2004) (62)
Challenge with gliadin induces eosinophil and mast cell activation in the jejunum of patients with celiac disease. (1989) (62)
The Role of The Human Neutrophil in the Inflammatory Reaction (1980) (62)
Oral N-acetylcysteine reduces selected humoral markers of inflammatory cell activity in BAL fluid from healthy smokers: correlation to effects on cellular variables. (1988) (61)
Eosinophils and eosinophil cationic protein in nasal lavages in allergen‐induced hyperresponsiveness: effects of topical glucocorticosteroid treatment (1989) (60)
Myeloperoxidase in human lung lavage (1990) (60)
Cationic proteins of human granulocytes. IV. Esterase activity. (1975) (60)
The combined action of hyaluronic acid and fibronectin stimulates neutrophil migration. (1985) (60)
Clinical and analytical performance of the liaison cardiac troponin I assay in unstable coronary artery disease, and the impact of age on the definition of reference limits. A FRISC-II substudy. (2003) (59)
Serum eosinophil cationic protein in relation to bronchial asthma in a young Swedish population (1994) (59)
Nasal patency and lavage biomarkers in relation to settled dust and cleaning routines in schools. (1999) (58)
High-sensitive cardiac troponin T outperforms novel diagnostic biomarkers in patients with acute chest pain. (2012) (58)
Cationic proteins of human granulocytes. I. Isolation of the cationic proteins from the granules of leukaemic myeloid cells. (2009) (58)
Myeloperoxidase and lactoferrin of blood neutrophils and plasma in chronic granulocytic leukaemia. (2009) (58)
Gluten sensitivity in patients with IgA nephropathy. (2009) (58)
Acute Effects of a Fungal Volatile Compound (2005) (58)
The functional heterogeneity of eosinophil cationic protein is determined by a gene polymorphism and post‐translational modifications (2007) (58)
The eosinophil and airway remodelling in asthma (2010) (57)
Early diagnosis and exclusion of acute myocardial infarction using biochemical monitoring. The BIOMACS Study Group. Biochemicals Markers of Acute Coronary Syndromes. (1995) (56)
An enzyme-linked immunosorbent assay for human carcinoembryonic antigen-related cell adhesion molecule 8, a biological marker of granulocyte activities in vivo. (2004) (56)
Eosinophil Cationic Protein Stimulates TGF-β1 Release by Human Lung Fibroblasts In Vitro (2007) (55)
Effect of long-term treatment with inhaled budesonide or theophylline on lung function, airway reactivity and asthma symptoms. (2002) (55)
Myoglobin turnover--influence of renal and extrarenal factors. (1978) (54)
The Influence of Serum on Random Migration and Chemotaxis of Polymorphonuclear Leucocytes: Methodological Evaluation using Sera from Infection‐prone Patients and Normals (1980) (54)
The eosinophil and asthma (1991) (53)
Activation of inflammatory systems during cardiopulmonary bypass. (1988) (52)
Eosinophilic cationic protein (ECP) in skin disorders. (1991) (52)
Changes of symptoms, tear film stability and eosinophilic cationic protein in nasal lavage fluid after re-exposure to a damp office building with a history of flooding. (2007) (52)
Migratory responses of eosinophil and neutrophil granulocytes from patients with asthma. (1990) (52)
Cell specific markers for eosinophils and neutrophils in sputum and bronchoalveolar lavage fluid of patients with respiratory conditions and healthy subjects (2002) (52)
In vitro studies of the interaction between heparin and eosinophil cationic protein (1991) (52)
Early and late outcome prediction of death in the emergency room setting by point-of-care and laboratory assays of cardiac troponin I. (2010) (51)
Myeloperoxidase is not useful for the early assessment of patients with chest pain. (2010) (51)
Factors influencing the 99th percentile of cardiac troponin I evaluated in community-dwelling individuals at 70 and 75 years of age. (2013) (51)
A rapid troponin I assay is not optimal for determination of troponin status and prediction of subsequent cardiac events at suspicion of unstable coronary syndromes. (2004) (50)
Are blood eosinophil number and activity important for the development of the late asthmatic reaction after allergen challenge? (1989) (50)
How to use C-reactive protein in acute coronary care. (2013) (50)
Granulocyte colony‐stimulating factor (G‐CSF) induces the production of cytokines in vivo (2000) (50)
The effect of granulocyte colony‐stimulating factor (G‐CSF) on the degranulation of secondary granule proteins from human neutrophils in vivo may be indirect (1996) (49)
Clinical implications of the change of cardiac troponin I levels in patients with acute chest pain - an evaluation with respect to the Universal Definition of Myocardial Infarction. (2011) (49)
Roller and centrifugal pumps compared in vitro with regard to haemolysis, granulocyte and complement activation (1994) (49)
The differential release of eosinophil granule proteins. Studies on patients with acute bacterial and viral infections (1995) (49)
Nasal challenge shows pathogenetic relevance of specific IgE serum antibodies for nasal symptoms caused by hexahydrophthalic anhydride (1994) (49)
The 434(G>C) polymorphism within the coding sequence of Eosinophil Cationic Protein (ECP) correlates with the natural course of Schistosoma mansoni infection. (2007) (49)
Admission N-terminal pro-brain natriuretic peptide and its interaction with admission troponin T and ST segment resolution for early risk stratification in ST elevation myocardial infarction (2005) (48)
Evidence of mast cell activity in the middle ears of children with otitis media with effusion (1999) (48)
Association of plasma neutrophil gelatinase-associated lipocalin (NGAL) with sepsis and acute kidney dysfunction (2013) (47)
NT-proBNP is a powerful predictor for incident atrial fibrillation - Validation of a multimarker approach. (2016) (47)
Expression of the C5a receptor (CD88) on granulocytes and monocytes in patients with severe sepsis (2002) (47)
Enhancement of urokinase-induced plasminogen activation by the cationic protein of human eosinophil granulocytes. (1979) (47)
Angiostrongylus cantonensis: role of eosinophils in the neurotoxic syndrome (Gordon-like phenomenon). (1989) (47)
What is the role of the eosinophil? (1990) (46)
Eosinophil cationic protein alters pulmonary surfactant structure and function in asthma. (2004) (46)
Cardiac troponin I levels in patients with non-ST-elevation acute coronary syndrome-the importance of gender. (2014) (46)
Duraflo II coating of cardiopulmonary bypass circuits reduces complement activation, but does not affect the release of granulocyte enzymes : a European multicentre study. (1997) (46)
High-Sensitivity Cardiac Troponin I Is a Strong Predictor of Cardiovascular Events and Mortality in the AGES-Reykjavik Community-Based Cohort of Older Individuals. (2016) (45)
The formation of eosinophil and neutrophil chemotactic activity during a pollen season and after allergen challenge. (1989) (45)
Lateral flow immunoassay using Europium (III) chelate microparticles and time-resolved fluorescence for eosinophils and neutrophils in whole blood. (2007) (45)
Polymorphism of the eosinophil cationic protein‐gene is related to the expression of allergic symptoms (2002) (45)
New generation cardiac troponin I assay for the access immunoassay system. (2001) (45)
Disparity in blood activation by two different heparin-coated cardiopulmonary bypass systems. (1995) (45)
LOW LEVELS OF EOSINOPHIL CATIONIC PROTEINS IN PATIENTS WITH ASTHMA (1977) (45)
Serum-levels of lactoferrin, lysozyme and myeloperoxidase in normal, infection-prone and leukemic children. (1984) (44)
Lactoferrin, Lysozyme, and β2‐Microglobulin in Cerebrospinal Fluid: Elevated Levels in Patients with Acute Cerebrovascular Lesions as Indices of Inflammation (1981) (44)
Current understanding of the role of the eosinophil granulocyte in asthma (1991) (44)
Effect of Hyaluronic Acid on Phagocytosis of Opsonized Latex Particles (1980) (44)
Radioimmunoassays of human myoglobin in serum and urine. (1979) (43)
Mucosal reactivity to cow's milk protein in coeliac disease (2007) (43)
Acute exacerbations of COPD: identification of biological clusters and their (2011) (43)
Inflammation markers in nasal lavage, and nasal symptoms in relation to relocation to a newly painted building: a longitudinal study (1999) (42)
New Method for the Measurement of Eosinophil Migration (1987) (42)
Neutrophils and eosinophils (1996) (41)
Subcutaneous administration of hyaluronan reduces the number of infectious exacerbations in patients with chronic bronchitis. (1996) (41)
Interaction and complex-formation between the eosinophil cationic protein and alpha 2-macroglobulin. (1987) (41)
Human neutrophil lipocalin (HNL) is a specific granule constituent of the neutrophil granulocyte. Studies in bronchial and lung parenchymal tissue and peripheral blood cells (1997) (41)
Relationship between sleep‐disordered breathing and markers of systemic inflammation in women from the general population (2012) (40)
Effect of 1 year daily treatment with 400 microg budesonide (Pulmicort Turbuhaler) in newly diagnosed asthmatics. (1997) (40)
Levels of Eosinophil Cationic Protein and Myeloperoxidase from Chronic Middle Ear Effusion in Patients with Allergy and/or Acute Infection. (1996) (40)
The identification of a phospholipase B precursor in human neutrophils (2009) (40)
Eosinophil cationic protein (ECP). (1998) (39)
The eosinophil granule proteins in serum, but not the oxidative metabolism of the blood eosinophils, are increased in cancer (1997) (39)
Interleukin-17A mRNA and protein expression within cells from the human bronchoalveolar space after exposure to organic dust (2005) (39)
Effects of in vivo administration of G‐CSF on neutrophil and eosinophil adhesion (1997) (39)
Troponin-specific autoantibody interference in different cardiac troponin I assay configurations. (2012) (38)
Eosinophil involvement in rheumatoid arthritis as reflected by elevated serum levels of eosinophil cationic protein. (1985) (38)
Kinetic studies of phagocytosis. (1978) (37)
Blood Eosinophils and Eosinophil Cationic Protein after Acute Myocardial Infarction or Corticosteroid Administration (1979) (37)
Bronchial mucosal mast cells in asymptomatic smokers relation to structure, lung function and emphysema. (2005) (37)
Human neutrophil lipocalin, a highly specific marker for acute exacerbation in cystic fibrosis. (1999) (37)
Glutathione in bronchoalveolar lavage fluid from smokers is related to humoral markers of inflammatory cell activity (1989) (37)
Monitoring of asthma inflammation by serum measurements of eosinophil cationic protein (ECP). A new clinical approach to asthma management. (1995) (37)
Noninvasive risk stratification in unstable coronary artery disease: exercise test and biochemical markers. FRISC Study Group. (1997) (37)
Exercise-induced asthma and the generation of neutrophil chemotactic activity. (1990) (36)
Eosinophil cationic protein is stored in, but not produced by, peripheral blood neutrophils (2002) (36)
Eosinophil cationic protein (ECP) in saliva: a new marker of disease activity in bronchial asthma. (2001) (36)
Changes in the ocular and nasal signs and symptoms of aircrews in relation to the ban on smoking on intercontinental flights. (2000) (35)
Coagulation and fibrinolysis during the normal menstrual cycle. (1989) (35)
Inflammation and structural changes in the airways of patients with primary Sjögren's syndrome. (2001) (35)
Inflammatory system activation during cardiopulmonary bypass as an indicator of biocompatibility: a randomized comparison of bubble and membrane oxygenators. (1990) (35)
Bronchial reactivity in asthmatic children at high and low altitude. Effect of budesonide. (1995) (35)
The eosinophil granulocyte in psoriasis (1990) (35)
Priming of eosinophil and neutrophil migratory responses by interleukin 3 and interleukin 5 (1994) (34)
Differences in blood activation related to roller/centrifugal pumps and heparin coated/uncoated surfaces in a cardiopulmonary bypass model circuit (1996) (34)
Bubble and membrane oxygenators--comparison of postoperative organ dysfunction with special reference to inflammatory activity. (1990) (34)
Eosinophil cationic protein (ECP), eosinophil chemotactic activity (ECA), neutrophil chemotactic activity (NCA) and tryptase in serum before and during bronchial challenge in cat‐allergic children with asthma (1992) (33)
Heparin-coated cardiopulmonary bypass circuits reduce circulating complement factors and interleukin-6 in paediatric heart surgery. (2000) (33)
Clinical assessment of the inflammatory component of asthma with emphasis on the eosinophils (1992) (33)
Plasma prolylcarboxypeptidase (angiotensinase C) is increased in obesity and diabetes mellitus and related to cardiovascular dysfunction. (2012) (33)
CC chemokine receptors CCR1 and CCR4 are expressed on airway mast cells in allergic asthma. (2005) (33)
The impact of atopy on neutrophil activity in middle ear effusion from children and adults with chronic otitis media. (2002) (33)
Complete heparin-coated cardiopulmonary bypass and low heparin dose reduce complement and granulocyte activation. (1996) (33)
Human Neutrophil Lipocalin as a Superior Diagnostic Means To Distinguish between Acute Bacterial and Viral Infections (2015) (33)
Human neutrophil lipocalin: normal levels and use as a marker for invasive infection in the newborn (2004) (33)
Allergen-induced changes in nasal secretory responsiveness and eosinophil granulocytes. (1991) (33)
Hemodialysis-induced increase in serum lactoferrin and serum eosinophil cationic protein as signs of local neutrophil and eosinophil degranulation. (1981) (32)
Eosinophil activity in bronchial asthma. (1994) (32)
The FRISC experience with troponin T. Use as decision tool and comparison with other prognostic markers. (1998) (32)
Serum eosinophil cationic protein, eosinophil protein X and eosinophil peroxidase in relation to pulmonary function in cystic fibrosis (1998) (31)
CD64 (Fcγ receptor I) cell surface expression on maturing neutrophils from preterm and term newborn infants (2005) (31)
Haptoglobin comprises about 10% of granule protein extracted from bovine granulocytes isolated from healthy cattle. (2007) (31)
Acoustic rhinometry and lavage biomarkers in relation to some building characteristics in Swedish schools. (2001) (31)
The Role of the Eosinophil Granulocyte in the Inflammatory Reaction (1979) (31)
The Presence of Eosinophil Cationic Protein in Middle Ear Effusion (1993) (31)
A fast and sensitive radioimmunoassay of human myoglobin for use in the early diagnosis of heart infarction. (1980) (31)
Gut mucosal granulocyte activation precedes nitric oxide production: studies in coeliac patients challenged with gluten and corn (2005) (30)
Neutrophil and eosinophil degranulation during hemodialysis are mediated by the dialysis membrane. (1982) (30)
The EvA study: aims and strategy (2012) (30)
Uncoordinated production of Laminin-5 chains in airways epithelium of allergic asthmatics (2005) (30)
A SELDI‐TOF MS study of the genetic and post‐translational molecular heterogeneity of eosinophil cationic protein (2007) (30)
Calprotectin, a new biomarker for diagnosis of acute respiratory infections (2020) (30)
Admission Troponin T and measurement of ST-segment resolution at 60 min improve early risk stratification in ST-elevation myocardial infarction. (2004) (30)
The Coding ECP 434(G>C) Gene Polymorphism Determines the Cytotoxicity of ECP but Has Minor Effects on Fibroblast-Mediated Gel Contraction and No Effect on RNase Activity1 (2009) (30)
Human eosinophil-derived neurotoxin and eosinophil protein X are likely the same protein. (1989) (30)
Urinary neutrophil gelatinase-associated lipocalin (NGAL) is associated with mortality in a community-based cohort of older Swedish men. (2013) (30)
Kinetics of mucosal granulocyte activation after gluten challenge in coeliac disease (2005) (29)
Peripheral blood markers: evaluation of inflammation in asthma. (1998) (29)
A method to study apoptosis in eosinophils by flow cytometry. (2000) (29)
Kinetic studies of cell migration in a modified Boyden chamber: dependence on cell concentration and effects of the chymotrypsin-like cationic protein of human granulocytes. (1979) (29)
Increased nitric oxide in expired air in patients with Sjögren′s syndrome (1999) (29)
Cardiac troponin I levels in an elderly population from the community--The implications of sex. (2015) (29)
Myeloperoxidase in human lung lavage (1990) (29)
Circulating cytokines and granulocyte-derived enzymes during complex heart surgery. A clinical study with special reference to heparin-coating of cardiopulmonary bypass circuits. (1995) (29)
Eosinophil cationic protein in inflammatory synovial effusions as evidence of eosinophil involvement. (1984) (29)
Closure of patent ductus arteriosus decreases pulmonary myeloperoxidase in premature infants with respiratory distress syndrome. (1995) (29)
Human neutrophil lipocalin (HNL) as a diagnostic tool in children with acute infections: A study of the kinetics (2005) (28)
The distribution of myeloperoxidase, eosinophil cationic protein, albumin and urea in sequential bronchoalveolar lavage. (1991) (28)
Eosinophil Cationic Protein (ECP) Is Processed during Secretion1 (2009) (28)
Prognostic usefulness of the change in N-terminal pro B-type natriuretic peptide levels to predict mortality in a single community cohort aged ≥ 70 years. (2013) (27)
Human neutrophil lipocalin: a specific marker for neutrophil activation in severe Plasmodium falciparum malaria. (2003) (27)
Blood eosinophil leucocyte and eosinophil cationic protein. In vivo study of the influence of beta-2-adrenergic drugs and steroid medication. (1978) (27)
Early diagnosis and exclusion of acute myocardial infarction using biochemical monitoring (1995) (27)
The molecular basis of the hyaluronic acid-mediated stimulation of granulocyte function. (1987) (27)
Effects of drainage in the treatment of acute maxillary sinusitis. (1983) (27)
Clinical and prognostic implications of circulating pentraxin 3 levels in non ST-elevation acute coronary syndrome. (2013) (27)
Cationic proteins of human granulocytes. V. Interaction with plasma protease inhibitors. (1975) (27)
Dexamethasone Treatment of Infants at Risk for Chronic Lung Disease: Surfactant Components and Inflammatory Parameters in Airway Specimens (1994) (27)
Effects of heparin coating on the expression of CD11b, CD11c and CD62L by leucocytes in extracorporeal circulation in vitro (1997) (26)
Predictors of histology, tissue eosinophilia and mast cell infiltration in Hodgkin’s Lymphoma – a population‐based study (2011) (26)
Regional generation of free oxygen radicals during cardiopulmonary bypass in children. (1995) (26)
Granulocyte proteases in human maxillary sinus secretions. (1983) (26)
Kinetic studies of phagocytosis. II. The serum-independent uptake of IgG-coated particles by polymorphonuclear leukocytes from uremic patients on regular dialysis treatment. (1979) (26)
Studies on the phagocytic activity of the granulocytes in psoriasis and palmoplantar pustulosis (1983) (26)
Eosinophil and neutrophil granulocytes (1993) (26)
The peroxidase activity and cellular content of granule proteins in PMN during pregnancy (1983) (25)
Serum eosinophilic cationic protein and lactoferrin related to smoking history and lung function. (1994) (25)
The Effect of Air Humidification on Symptoms and Nasal Patency, Tear Film Stability, and Biomarkers in Nasal Lavage: A 6 Weeks’ Longitudinal Study (2000) (25)
Cell surface expression of FcγRI (CD64) on neutrophils and monocytes in patients with influenza A, with and without complications (2005) (25)
The monitoring of inflammation by specific cellular markers. (1994) (25)
Biocompatibility of heparin-coated circuits used in cardiopulmonary bypass. (1994) (25)
Measurements of ECP in serum and the impact of plasma coagulation (2000) (25)
Releasability of human hypereosinophilic eosinophils is related to the density of the cells (1994) (25)
No benefit of reduced heparinization in thoracic aortic operation with heparin-coated bypass circuits. (2000) (25)
Cationic Proteins of Human Granulocytes (1975) (25)
Cardiac troponin assay classification by both clinical and analytical performance characteristics: a study on outcome prediction. (2013) (25)
Oxygen radical production by blood eosinophils is reduced during birch pollen season in allergic patients (1996) (24)
Eosinophil cationic protein (ECP) in the cerebrospinal fluid (1983) (24)
Regulation of human eosinophil migration across lung epithelial monolayers by distinct calcium signaling mechanisms in the two cell types. (1999) (24)
Blood eosinophil count and airway epithelial transcriptome relationships in COPD versus asthma (2019) (24)
Eosinophil Cationic Protein Stimulates Migration of Human Lung Fibroblasts In Vitro (2009) (24)
Clinical performance of a new point-of-care cardiac troponin I assay compared to three laboratory troponin assays. (2011) (24)
Periodontitis in the primary dentition associated with Actinobacillus actinomycetemcomitans infection and leukocyte dysfunction. A 3 1/2 year follow-up. (1990) (24)
Muscle cell leakage of myoglobin after long-term exercise and relation to the individual performances. (1986) (24)
Kinetic studies of phagocytosis of IgG-coated latex particles with a thrombocyte counter. (1977) (24)
Possible reasons for the prognostic value of troponin‐T on admission in patients with ST‐elevation myocardial infarction (2001) (24)
Soluble adhesion molecules, cytokines and cellular markers in serum in patients with acute infections. (2001) (23)
Influence of personal factors on nasal patency and lavage biomarkers in white-collar workers. (2000) (23)
Mast cells and tryptase in the middle ear of children with otitis media with effusion. (1999) (23)
Effects of rhinovirus-induced common colds on granulocyte activity in allergic rhinitis. (2002) (23)
Eosinophil peroxidase: a new serum marker of atopy and bronchial hyper-responsiveness. (1996) (23)
Inflammatory markers of outcome. (1996) (23)
Neutrophil function in chronic bronchitis. (1991) (23)
Fixed airflow obstruction relates to eosinophil activation in asthmatics (2018) (23)
Adiponectin and cardiac geometry and function in elderly: results from two community-based cohort studies. (2010) (23)
High-sensitive troponin T and I are related to invasive hemodynamic data and mortality in patients with left-ventricular dysfunction and precapillary pulmonary hypertension. (2011) (23)
Lucigenin-enhanced chemiluminescence in blood is increased in cancer. (1989) (23)
Effect of eosinophil cationic protein (ECP) on Hodgkin lymphoma cell lines. (2011) (23)
Relationship Between Sleep-disordered Breathing And Markers Of Systemic Inflammation In Women From The General Population (2010) (23)
Kinetic studies of neutrophil phagocytosis. V. studies on the co-operation between the Fc and C3b receptors. (1982) (23)
Effects of heparin coating of cardiopulmonary bypass circuits on in vitro oxygen free radical production during coronary bypass surgery. (1996) (22)
Equal clinical performance of a novel point-of-care cardiac troponin I (cTnI) assay with a commonly used high-sensitivity cTnI assay. (2017) (22)
Is it time to do away with the 99th percentile for cardiac troponin in the diagnosis of acute coronary syndrome and the assessment of cardiac risk? (2014) (22)
A (G→C) transversion in the 3′ UTR of the human ECP (eosinophil cationic protein) gene correlates to the cellular content of ECP (2006) (22)
Gastrointestinal sensitivity to soy and milk proteins in patients with IgA nephropathy. (2010) (22)
Heat-labile neutrophil chemotactic activity in subjects with asthma after allergen inhalation: relation to the late asthmatic reaction and effects of asthma medication. (1987) (22)
Priming of eosinophil migration across lung epithelial cell monolayers and upregulation of CD11b/CD18 are elicited by extracellular Ca2+. (2003) (22)
CD64 (Fcgamma receptor I) cell surface expression on maturing neutrophils from preterm and term newborn infants. (2005) (22)
Autoantibodies to cardiac troponin in acute coronary syndromes. (2010) (21)
Markers for eosinophils and T‐lymphocytes as predictors of late asthmatic response (1993) (21)
B-type natriuretic peptides and their relation to cardiovascular structure and function in a population-based sample of subjects aged 70 years. (2009) (21)
Generation of Heat‐Labile Chemotactic Activity in Blood after Inhalation Challenge and its Relationship to Neutrophil and Monocyte/Macrophage Turnover and Activity (1982) (21)
Cow's milk protein sensitivity assessed by the mucosal patch technique is related to irritable bowel syndrome in patients with primary Sjögren's syndrome (2008) (21)
The Serum Levels of Eosinophil Cationic Protein (ECP) Are Related to the Infiltration of Eosinophils in the Tumours of Patients with Hodgkin's Disease (2001) (21)
Activity and turnover of eosinophil and neutrophil granulocytes are altered in visceral leishmaniasis. (2011) (21)
Circulating adhesion molecules in allergic and non-allergic asthma. (2005) (21)
Associations of mid-regional pro-adrenomedullin levels to cardiovascular and metabolic abnormalities, and mortality in an elderly population from the community. (2013) (21)
Elastase in the different primary granules of the human neutrophil. (1985) (21)
Pathophysiologic mechanisms of persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome. (2008) (21)
Neutrophil and monocyte receptor expression in uncomplicated and complicated influenza A infection with pneumonia (2008) (21)
Kinetic studies of phagocytosis. I. The serum independent particle uptake by PMN from patients with rheumatoid arthritis and systemic lupus erythematosus. (1978) (20)
Locomotion of neutrophil granulocytes from patients with thermal injury. Identification of serum-derived inhibitors (1981) (20)
Raised circulating levels of the eosinophil cationic protein in ankylosing spondylitis: relation with the inflammatory activity and the influence of sulphasalazine treatment. (1987) (20)
Transfer of 99mTc DTPA and bronchoalveolar lavage findings in patients with asymptomatic extrinsic allergic alveolitis. (1990) (20)
Platelet adhesion in patients prone to arterial and venous thrombosis: the impact of gender, smoking and heredity. (1998) (20)
Urinary neutrophil gelatinase-associated lipocalin to hepcidin ratio as a biomarker of acute kidney injury in intensive care unit patients. (2015) (20)
Serum and plasma measurements of neutrophil granule proteins during cardiopulmonary bypass: A model to estimate human turnover of lactoferrin and myeloperoxidase (1987) (20)
Human alveolar macrophages from smokers have an impaired capacity to secrete LTB4 but not other chemotactic factors. (1987) (20)
The Chemotactic Response of Granulocytes to the Low Molecular Weight Chemoattractants f‐MLP, C5f, and LTB4 Is Dependent on Chemokinetic Factors (1985) (20)
The human eosinophil in inflammation (2005) (19)
Cystatin C as a marker of immune complex-associated renal impairment in a Sudanese population with visceral leishmaniasis. (2006) (19)
Chemotactic Activity of LTB4 in Man (1986) (19)
Radioimmunoassay of serum myoglobin in neuromuscular diseases. (1981) (19)
Serum ferritin during inflammation. A study on myocardial infarction. (2009) (19)
Increased chemokinetic and chemotactic responses of eosinophils in asthmatic patients (1991) (19)
Distinction between bacterial and viral infections by serum measurement of human neutrophil lipocalin (HNL) and the impact of antibody selection. (2016) (19)
IL‐5 priming of the PMA‐induced oxidative metabolism of human eosinophils from allergic and normal subjects during a pollen season (2001) (19)
Diagnosis, size estimation and prediction of acute myocardial infarction from S-myoglobin observations. A system analysis to assess the influence of various sources of variability. (1980) (19)
Serum and urinary myoglobin in alcoholics. (2009) (18)
Influence of Two Blood Conservation Techniques (Cardiotomy Reservoir Versus Cell‐Saver) on Biocompatibility of the Heparin Coated Cardiopulmonary Bypass Circuit During Coronary Revascularization Surgery (1997) (18)
Protein post‐translational modification in host defense: the antimicrobial mechanism of action of human eosinophil cationic protein native forms (2014) (18)
Self-reported food intolerance and mucosal reactivity after rectal food protein challenge in patients with rheumatoid arthritis (2010) (18)
Increased in vivo activation of neutrophils and complement in sickle cell disease. (1993) (18)
Eosinophil granule proteins in cardiopulmonary bypass with and without heparin coating. (1995) (18)
Glucocorticosteroids, Inflammation and Bronchial Hyperreactivity1, 2 (1985) (18)
Lactoferrin, lysozyme, and beta 2-microglobulin levels in cerebrospinal fluid: differential indices of CNS inflammation. (1982) (18)
Granulocytes and their secretory products, myeloperoxidase and eosinophil cationic protein, in bronchoalveolar lavage fluids from two lung lobes in normal subjects. (1991) (17)
Elevation of cardiac troponins measured after recreational resistance training. (2015) (17)
C5a, Interleukin‐8 and Tumour Necrosis factor‐α‐Induced Changes in Granulocyte and Monocyte Expression of Complement Receptors in Whole Blood and on Isolated Leukocytes (2006) (17)
Differential Expression of the C5a Receptor and Complement Receptors 1 and 3 after LPS Stimulation of Neutrophils and Monocytes (2004) (17)
Eosinophils and cellular injury: the Gordon phenomenon as a model. (1985) (17)
Myeloid regeneration after bone‐marrow transplantation monitored by serum measurements of my eloper oxidase, lysozyme and lactoferrin (1987) (17)
Eosinophils and neutrophils in biopsies from the middle ear of atopic children with otitis media with effusion (1999) (17)
Monocytes, but not macrophages, produce the eosinophil cationic protein (2001) (17)
Short- and long-term individual variation in NT-proBNP levels in patients with stable coronary artery disease. (2013) (17)
Ultrastructural characterization of platelet-activating factor-stimulated human eosinophils from patients with asthma. (1993) (16)
Evaluation of four sensitive troponin assays for risk assessment in acute coronary syndromes using a new clinically oriented approach for comparison of assays (2013) (16)
Mid-regional pro-atrial natriuretic peptide levels in the elderly: clinical and prognostic implications, and comparison to B-type natriuretic peptides. (2013) (16)
Risk prediction in chest pain patients by biochemical markers including estimates of renal function. (2008) (16)
Partial Characterization and Identification of Chemokinetic Factors in Serum (1983) (16)
Recurrent pyoderma gangrenosum and cystic acne associated with leucocyte adhesion deficiency due to novel mutations in ITGB2: successful treatment with infliximab and adalimumab. (2015) (16)
Eosinophil and neutrophil activity in blood in asthma in a one-year-double-blind trail with Theophylline and two doses of inhaled Budesonide. The impact of smoking (1995) (16)
Defects in polymorphonuclear neutrophil function and susceptibility to infection in children. (1986) (16)
Administration of G‐CSF to healthy subjects: the effects on eosinophil counts and mobilization of eosinophil granule proteins (1997) (16)
Evaluation of Temporal Changes in Cardiovascular Biomarker Concentrations Improves Risk Prediction in an Elderly Population from the Community. (2016) (16)
Kinetic retrieval of eosinophil cationic protein, hyaluronan, secretory IgA, albumin, and urea during BAL in healthy subjects. (1995) (16)
Human neutrophil lipocalin in fMLP-activated whole blood as a diagnostic means to distinguish between acute bacterial and viral infections. (2015) (15)
Lactoferrin, lysozyme, and β2-Microglobulin levels in cerebrospinal fluid (1982) (15)
Mechanisms of basal and cytokine-induced uptake of glucose in normal human eosinophils: relation to apoptosis. (2003) (15)
Subcellular localization and mobilization of carcinoembryonic antigen‐related cell adhesion molecule 8 in human neutrophils (2004) (15)
Eosinophil chemotactic activity in allergic patients during the birch pollen season: the effect of immunotherapy. (1987) (15)
Human neutrophil lipocalin (HNL) and myeloperoxidase (MPO). Studies of lung lavage fluid and lung tissue. (2000) (15)
Eosinophil associated genes in the inflammatory bowel disease 4 region: correlation to inflammatory bowel disease revealed. (2012) (15)
The eosinophil granulocyte in allergic inflammation (1993) (15)
Associations of ECP (eosinophil cationic protein)-gene polymorphisms to allergy, asthma, smoke habits and lung function in two Estonian and Swedish sub cohorts of the ECRHS II study (2010) (15)
Chemiluminescence of polymorphonuclear leukocytes and whole blood during acute bacterial infection. (1989) (14)
Increased nitric oxide in expired air in patients with Sjögren's syndrome. BHR study group. Bronchial hyperresponsiveness. (1999) (14)
Hyaluronic acid stimulates neutrophil function in vitro and in vivo. A review of experimental results and a presentation of a preliminary clinical trial. (1980) (14)
Effects of UVB treatment on neutrophil function in psoriatic patients and healthy subjects. (1990) (14)
Acoustic rhinometry in epidemiological studies--nasal reactions in Swedish schools. (2000) (14)
Neutrophil function in infection-prone children. (1980) (14)
Inflammation : basic mechanisms, tissue injuring principles, and clinical models (1985) (13)
The Chemotactic Activity of Normal and Complement‐Activated Serum as Measured by the Leading‐Front Method Using a Boyden Chamber (1984) (13)
Muscle ATP and lactate and the release of myoglobin and carbanhydrase III in acute lower-limb ischaemia. (1991) (13)
Multicentre evaluation of a high sensitive Elecsys troponin T assay (2009) (13)
Measurement of natriuretic peptides at the point of care in the emergency and ambulatory setting: current status and future perspectives. (2013) (13)
Neutrophil and eosinophil involvement of the small bowel affected by chronic alcoholism. (1988) (12)
β2‐Microglobulin, lysozyme and lactoferrin in cerebrospinal fluid in patients with lymphoma or leukaemia: relationship to CNS involvement and the effect of prophylactic intrathecal treatment with methotrexate (1987) (12)
Identification of a chemokinetic inhibitor in serum from patients with chronic lymphocytic leukaemia. (2009) (12)
Diagnostic and prognostic significance of serum measurements of lactoferrin, lysozyme and myeloperoxidase in acute myeloid leukemia (AML): Recognition of a new variant, high‐lactoferrin AML (1987) (12)
Interleukin‐2 inhibits eosinophil migration but is counteracted by IL‐5 priming (2001) (12)
Lactoferrin, myeloperoxidase, lysozyme and eosinophil cationic protein in exudate in delayed type hypersensitivity (1988) (12)
99mTc‐HMPAO (Ceretec) is stored in and released from the granules of eosinophil granulocytes (2001) (12)
Activation of Blood Coagulation during Inhalation Challenge Tests (1981) (12)
Blood eosinophil leucocytes and eosinophil cationic protein. Diurnal variation in normal subjects and patients with bronchial asthma. (1978) (12)
Ankylosing spondylitis: a chronic inflammatory disease with iron overload in granulocytes and platelets. (1986) (12)
Serum ferritin during infection. A longitudinal study in renal transplant patients. (2009) (12)
Some aspects of neutrophil granulocyte function in burn patients (1979) (11)
Comparison between Second and Third Generation Troponin T Assay in Patients with Symptoms Suggestive of an Acute Coronary Syndrome but without ST Segment Elevation (2003) (11)
Neutrophil leucocyte activation in severe malaria. (1996) (11)
Bone-marrow regeneration after therapy-induced hypoplasia monitored by serum measurements of lactoferrin, lysozyme and myeloperoxidase. (2009) (11)
Elevated Serum Levels of Lactoferrin and Eosinophil Cationic Protein in Schizophrenic Patients (1982) (11)
Human neutrophil lipocalin (HNL) as a biomarker of acute infections (2018) (11)
Evaluation of a development version of the elecsys high sensitive troponin T assay (2008) (11)
Role of the eosinophil in bronchial asthma. (1982) (11)
Inhibition of Neutrophil and Eosinophil Chemotactic Responses to PAF by the PAF‐Antagonists WEB‐2086, L‐652,731, and SRI‐63441 (1990) (11)
AroCell TK 210 ELISA for determination of TK1 protein: age-related reference ranges and comparison with other TK1 assays. (2020) (11)
Relation between cardiovascular disease risk markers and brain infarcts detected by magnetic resonance imaging in an elderly population. (2015) (10)
Human Neutrophil Lipocalin in Activated Whole Blood Is a Specific and Rapid Diagnostic Biomarker of Bacterial Infections in the Respiratory Tract (2017) (10)
Role of eosinophils in childhood asthma inflammation (1995) (10)
Myoglobinemia after myocardial infarction; influence of renal function. (1978) (10)
Variations in serum myoglobin after a 2-min isokinetic exercise test and the effects of training (2004) (10)
Novel sensitive cardiac troponin I immunoassay free from troponin I-specific autoantibody interference (2014) (10)
Increase in Net Activity of Serine Proteinases but Not Gelatinases after Local Endotoxin Exposure in the Peripheral Airways of Healthy Subjects (2013) (10)
Cardiac troponin I associated with the development of unrecognized myocardial infarctions detected with MRI. (2014) (10)
Total absence of eosinophils in a patient with chronic urticaria and vitiligo (1988) (10)
Performance of plasma measurement of neutrophil gelatinase-associated lipocalin as a biomarker of bacterial infections in the intensive care unit. (2019) (10)
Changes in inflammatory markers following treatment of acute exacerbations of obstructive pulmonary disease. (2001) (10)
Kinetic studies of phagocytosis. IV. Cellular defects and humoral inhibition as causes of impaired neutrophil phagocytosis in sarcoidosis. (1982) (10)
Elevated circulating levels of eosinophil cationic protein in uremia as signs of abnormal eosinophil homeostasis. (1984) (10)
The human eosinophil proteome. Changes induced by birch pollen allergy. (2009) (9)
Predictors of 10-year changes in levels of N-terminal pro B-type natriuretic peptide and cardiac troponin I in the elderly. (2018) (9)
Kinetic studies of phagocytosis. III. The complement-dependent opsonic and anti-opsonic effects of normal and sle sera. (1982) (9)
Ethanol reduces myoglobin release during isokinetic muscle exercise. (2009) (9)
NT-ProBNP in non-ST-elevation acute coronary syndrome. (2005) (9)
Myocardial and skeletal muscle function in habitual alcoholics and its relation to serum myoglobin. (1986) (9)
34 Eosinophils, secretory responsiveness and glucocorticoid-induced effects on the allergic nasal mucosa during a weak pollen season (1991) (9)
The Content of Eosinophil Cationic Protein in Eosinophil Leucocytes (1978) (9)
Phagocyte activation in preterm infants following premature rupture of the membranes or chorioamnionitis (2000) (9)
Unrecognized myocardial scars detected by delayed–enhanced MRI are associated with increased levels of NT-proBNP (2011) (8)
Eosinophil cationic protein in bullous pemphigoid, dermatitis herpetiformis and other blistering disorders (1993) (8)
Polymorphonuclear neutrophil function and infections following splenectomy in childhood. (2009) (8)
The chemokinetic inhibitory factor (CIF) in serum of CLL patients: correlation with infection propensity and disease activity. (2009) (8)
Neutrophil and eosinophil degranulation by hemodialysis membranes. (1984) (8)
Evaluation of urinary myoglobin assay test for myocardial infarction. (1978) (7)
Diagnosis and Monitoring of Acute Infections with Emphasis on the Novel Biomarker Human Neutrophil Lipocalin. (2019) (7)
Asparagine-linked glycans determine the cytotoxic capacity of eosinophil cationic protein (ECP). (2013) (7)
Defective C3b receptor-mediated phagocytosis of neutrophils in patients with primary biliary cirrhosis. (1987) (7)
Purification of a 75 kDa protein from the organelle matrix of human neutrophils and identification as N-acetylglucosamine-6-sulphatase. (2005) (7)
Patient reactions and granulocyte degranulation during hemodialysis with cuprophane and polycarbonate membranes. A double-blind study. (1986) (7)
Purification and characterization of a 95-kDa protein--carcinoembryonic antigen-related cell adhesion molecule 8--from normal human granulocytes. (2002) (7)
Prolonged gramulocyte activation, as well as hypoxanthine and free radical production after open heart surgery in children (1996) (7)
Prolyl carboxypeptidase activity in the circulation and its correlation with body weight and adipose tissue in lean and obese subjects (2018) (7)
Neutrophil phagocytosis in sarcoidosis. Reduced C3b receptor-mediated phagocytosis in active and silent sarcoidosis. (1985) (7)
Blood eosinophils from asymptomatic allergies have a reduced capacity to produce oxygen‐free radicals (1998) (6)
Sequential studies on serum-levels of lysozyme, lactoferrin and eosinophil cationic protein in alcoholics after alcohol withdrawal. (2009) (6)
Serum lysozyme – a surrogate marker of pulmonary microvascular injury in smokers? (2013) (6)
Cellular origin of the chemokinetic inhibitor of polymorphononuclear leucocytes found in sera from patients with chronic lymphocytic leukaemia. (2009) (6)
The mechanisms of serum‐treated zymosan (STZ)‐induced oxidative metabolism by human eosinophils and the effects of IL‐5 priming (2001) (6)
HNL (Human Neutrophil Lipocalin) and a multimarker approach to the distinction between bacterial and viral infections. (2019) (6)
Biomaterial-dependent blood activation during simulated extracorporeal circulation: a study of heparin-coated and uncoated circuits. (1997) (6)
Inflammatory markers in acute exacerbations of obstructive pulmonary disease: predictive value in relation to smoking history. (1999) (6)
Cationic proteins of human granulocytes: Enhancement of phagocytosis ofStaphylococcus protein A-IgG complexes (1976) (6)
Serum eosinophil cationic protein in asthma of farmers (2000) (6)
Bactericidal proteins and neutral proteases in diabetes neutrophils (1986) (6)
The diagnostic and prognostic value of serum-myoglobin determinations in acute myocardial infarction. (1983) (6)
Evaluation of Laboratory Markers for the Detection of Infections in Open-heart Surgery Patients (2003) (6)
Early rule out of acute myocardial infarction (2017) (6)
Hyaluronan and myeloperoxidase in human peritoneal fluid during genital inflammation (2005) (6)
The Effect of Air Humidification on Symptoms and Nasal Patency, Tear Film Stability, and Biomarkers in Nasal Lavage: A 6 Weeks' Longitudinal Study (2000) (5)
An Extragranular Compartment of Blood Eosinophils Contains Eosinophil Protein X/Eosinophil-Derived Neurotoxin (EPX/EDN) (2013) (5)
The Chemokinetic Inhibitory Factor Derived from Chronic Lymphocytic Leukaemia Cells (1986) (5)
Serum-mediated stimulation and inhibition of neutrophil locomotion in sarcoidosis. (1984) (5)
The Stimulus‐Dependent Release of Eosinophil Cationic Protein and Eosinophil Protein X Increases in Apoptotic Eosinophils (2003) (5)
Albumin Stimulation of Eosinophil Migration Involves PI3-Kinases and Is Associated with Diminished Eosinophil CD49d and CD49f Expression (2006) (5)
Multiple biomarkers and cardiovascular risk - Reply (2008) (5)
Prognostic implications of changes in cardiac troponin I levels in patients with non-ST elevation acute coronary syndrome (2013) (5)
Effects of heparin-coating of cardiopulmonary bypass circuits on leukocytes during simulated extracorporeal circulation. (1997) (5)
Indices of inflammatory cell activity and pulmonary function in different stages of sarcoidosis. (2009) (5)
Utility of B-type natriuretic peptides and cardiac troponins for population screening regarding cardiac abnormalities (2012) (5)
Gender specific airway gene expression in COPD sub-phenotypes supports a role of mitochondria and of different types of leukocytes (2021) (5)
Role of eosinophilic granulocytes in women with infertility and pelvic adhesions (1994) (5)
Concurrence of elevated FeNO and airway hyperresponsiveness in nonasthmatic adolescents (2020) (5)
Measurement of Specific Markers in the Monitoring of the Bronchial Inflammation in Asthma (1991) (5)
Transfer of 99 mTc DTPA and bronchoalveolar lavage findings in patients with asymptomatic extrinsic allergic alveolitis (5)
Cardiac troponin I, NT-proBNP and galactin-3 are elevated in patients with unrecognized myocardial infarction detected by cardiac magnetic resonance imaging (2014) (5)
Neutrophil function in patients with primary Sjögren's syndrome: relation to infection propensity. (1991) (5)
Specific binding of B‐CLL cell‐derived chemokinetic inhibitory factor (CIF) to human polymorphonuclear leukocytes (1987) (5)
Identification of a serum-derived promotor of granulocyte granule secretion: study on a patient with chronic pruritus. (1982) (4)
The inflammatory process : an introduction to the study of cellular and humoral mechanisms (1981) (4)
The eosinophil and intrinsic asthma. (1989) (4)
Eosinophils and respiratory disease. (2001) (4)
Increased in vivo secretory activity of neutrophil granulocytes in patients with psoriasis and palmoplantar pustulosis (2004) (4)
Production of chemokinetic inhibitory factor (CIF) by normal blood and spleen B lymphocytes. (1986) (4)
Nitric oxide increases leukocyte granule release during simulated extracorporeal circulation. (2000) (4)
Blood biomarker algorithms for the diagnosis of mycoplasma pneumoniae respiratory infections. (2020) (4)
Patients with renal cancer have a larger proportion of high-density blood monocytes with increased lucigenin-enhanced chemiluminescence (1994) (4)
Monocyte activation in patients with non-seminomatous germ cell tumour of the testis before and after tumour eradication. (1996) (4)
A critical look at blood samples in CB and COAD. (1990) (4)
Tissue localization and the establishment of a sensitive immunoassay of the newly discovered human phospholipase B-precursor (PLB-P). (2010) (4)
Serum myoglobin in thyroid disease. (1980) (4)
Cationic proteins of human granulocytes : isolation, characterization and biological activities (1975) (3)
No beneficial effect of 24-48 hours abciximab infusion in aspirin and heparin treated acute coronary syndrome patients with elevated troponin without early revascularisation procedures A GUSTO-IV ACS Substudy (2001) (3)
The production of the eosinophil proteins ECP and EPX/EDN are regulated in a reciprocal manner (2014) (3)
Coronary angiography in relation to troponin T level in patients with unstable coronary artery disease (UCAD) - a FRISC-2 substudy (2000) (3)
Expression of the C 5 a receptor ( CD 88 ) on granulocytes and monocytes in patients with severe sepsis (2015) (3)
The eosinophil cationic protein and the eosinophil in inflammatory reactions (1980) (3)
Metal content of neutrophil granules is altered in chronic inflammation (1989) (3)
Measurements of ECP in serum and the impact of plasma coagulation. (2000) (3)
Inverse relationship between interferon production by mononuclear leucocytes and oxidative metabolism of neutrophil granulocytes in infection prone children. (1985) (3)
Apoptotic eosinophils express IL-2R chains α and β and co-stimulatory molecules CD28 and CD86 (2003) (3)
Serum myoglobin concentrations are decreased by beta-adrenergic stimulation (2004) (3)
Ultrastructure of bronchial biopsies from patients with atopic and non-atopic asthma (2003) (3)
Systemic Human Neutrophil Lipocalin Associates with Severe Acute Kidney Injury in SARS-CoV-2 Pneumonia (2021) (3)
C3b‐induced eosinophil degranulation involves PI3‐kinases and is inhibited by protein kinase C activity (2011) (3)
Hyaluronan and myeloperoxidase in human peritoneal fluid during genital inflammation (1994) (3)
The effect of rGM‐CSF on neutrophil and eosinophil regeneration after ABMT as monitored by circulating levels of granule proteins (1994) (2)
Estimation of numbers of mature and immature neutrophils in blood by a novel, rapid and simple technology (2021) (2)
An immunofluorescent method for a specific demonstration of granulocytes and some of their proteins (ECP and CCP) (2004) (2)
Seemingly healthy 71‐year‐old men with minor elevations of cardiac troponin I and at risk of premature death in CVD have elevated levels of NT‐proBNP: Report from the ULSAM study (2009) (2)
Multiple biomarkers and cardiovascular risk. (2008) (2)
Kinetics of the Agglutination of IgG‐coated Latex Particles by Clq: the Influence of Heat‐labile Serum Components (1979) (2)
Acute Coronary Syndrome Prognostic Value of Biomarkers During and After NonST-Segment Elevation (2011) (2)
Su2086 A Pilot Study of Mesalazine Treatment in IBS, Evaluating the Tolerance and Usefulness of the Mucosal Patch Technique for Measurement of Rectal Inflammatory Markers (2014) (2)
Neutrophil locomotion and serum chemotactic and chemokinetic activities in pustulosis palmoplantaris compared with psoriasis (2004) (2)
The humaneosinophil and its role in airway remodeling (2001) (2)
The effect of hyaluronic acid on neutrophil function in vitro and in vivo. (1982) (2)
Eeosinophils in allergic contact dermatitis. (1992) (2)
Selective priming of peripheral blood eosinophils in patients with idiopathic hypereosinophilic syndrome (2006) (2)
297 Characterization of inflammation in asthma by measurement of mediators in bronchoalveolar lavage (BAL) (1991) (2)
Risk Stratification of Chest Pain N-Terminal Pro Brain Natriuretic Peptide on Admission for Early Risk Stratification of Patients With Chest Pain and No ST-Segment Elevation (2002) (2)
The effect of IL-5 treatment on the stimulation-induced phosphorylation of proteins in blood eosinophils. (2004) (2)
Serum levels of neutrophil and eosinophil chemotactic activities in mastocytosis (1989) (2)
Randomised clinical trial and meta‐analysis: mesalazine treatment in irritable bowel syndrome—effects on gastrointestinal symptoms and rectal biomarkers of immune activity (2022) (2)
Genetic analysis of coronary artery disease single nucleotide polymorphisms in diabetic nephropathy (2009) (2)
C5a receptor expression on leukocytes from patients with severe sepsis or septic shock (2001) (2)
Abstract 2060: Persisting Troponin I Elevations Predict Adverse Outcome in Stabilized Patients After an Episode of Acute Coronary Syndrome. (2006) (1)
Chemotactic properties of retained maxillary sinus secretions. (1984) (1)
Which markers of inflammation should be used in therapeutic intervention studies of CB/COAD? (1990) (1)
Apoptotic eosinophils express IL-2R chains alpha and beta and co-stimulatory molecules CD28 and CD86. (2003) (1)
[BNP or NT-proBNP should be analyzed in suspected heart failure. Guidelines for analysis and interpretation]. (2006) (1)
Enhanced Adhesion to Laminin by Apoptotic Eosinophils (2003) (1)
The genetically determined production of the alarmin eosinophil‐derived neurotoxin is reduced in visceral leishmaniasis (2018) (1)
Effects of Heparin-Coating of Cardiopulmonary Bypass Circuits on Leukocytes during Simulated Extracorporeal Circulation (1997) (1)
Indices of inflammatory activity in CB and COAD. Phagocyte secretion and chemotaxis. (1990) (1)
Serum levels of lactoferrin and myeloperoxidase in chronic idiopathic and secondary neutropenia. A preliminary report. (2009) (1)
[A rapid troponin T test in acute chest pain. Evaluation in the routine clinical work]. (1995) (1)
Cationic proteins of human granulocytes Effects on human platelet aggregation and serotonin release (1976) (1)
[Degranulation of human eosinophilic granulocytes by the platelet activating factor]. (1990) (1)
Acute Myocardial Infarction Low Molecular Weight Heparin ( Dalteparin ) as Adjuvant Treatment to Thrombolysis in Acute Myocardial Infarction — A Pilot Study : Biochemical Markers in Acute Coronary Syndromes ( BIOMACS II ) (2016) (1)
Troponin T Identiﬁes Patients With Unstable Coronary Artery Disease Who Beneﬁt From Long-Term Antithrombotic Protection (2016) (1)
A cross-sectional cohort study of the activity and turnover of neutrophil granulocytes in juvenile idiopathic arthritis (2021) (1)
T6 Acute exacerbations of chronic obstructive pulmonary disease: identification of phenotype-specific biomarkers and biological clusters (2010) (1)
Excellence in acute cardiac care: an overview of the seminar proceedings (2014) (1)
Inflammatory response during simulated extracorporeal circulation with addition of nitric oxide. (2000) (1)
884-2 Cardiac dysfunction in non-ST elevation ACS is partly reversible: Analysis of serial measurements of NT-Pro B-type natriutetic peptide (2004) (1)
9 – Eosinophil-Derived Pro-inflammatory Mediators (1993) (1)
Subject Index, Vol. 32, 1982 (1982) (1)
Immunoglobulin and inflammatory markers profiles in mycetoma. (1996) (1)
Eosinophilia and the Hypereosinophil Syndromes (2006) (0)
Receptors for phagocytosis and adhesion on neutrophil granulocytes in preterm infants (1994) (0)
[Hypovolemic shock with edema/hemoconcentration caused by periodic leakage of plasma proteins]. (1985) (0)
[Uppsala symposium on white blood corpuscles]. (1978) (0)
[Burdensome rules for clinical trials are not in proportion to benefits for the patient]. (2005) (0)
Phagocyte Activation in Preterm Infants (1999) (0)
Abstract 2618: The thymidine kinase 1 (TK1) protein concentration in sera from Hodgkin lymphoma patients: A marker for cell death and disruption of malignant cells (2018) (0)
P122. High dose nitric oxide enhances myeloperoxidase secretion and reverses neutrophil degranulation hierarchy in simulated extracorporeal circulation (2006) (0)
Abstract 1193: Unrecognized Myocardial Scars Detected by Delayed-enhanced Magnetic Resonance Imaging are Associated with Increased Levels Of N-terminal Pro-brain Natriuretic Peptide (2008) (0)
Post-translational glycosylations determine the cytotoxic capacity of Eosinophil Cationic Protein (ECP) (2007) (0)
Eosinophil cationic protein in inflammatory synovial effusions 557 Patients and methods PATIENTS AND SYNOVIAL FLUID COLLECTION (0)
EXPRESSION OF THE PHAGOCYTE RECEPTOR CD64 (FcγRI) ON NEUTROPHILS DURING INFECTION. † 1752 (1996) (0)
Periodontitis in the primary dentition associated with Actinobacillus actinomycetemcomitans infection and leukocyte dysfunction.: A 3½year follow-up (1992) (0)
C3b receptor-mediated phagocytosis in sarcoidosis with extra-thoracic manifestations. (1985) (0)
827-4 N terminal pro brain natriretic peptide is the most powerful predictor of long-term mortality in diabetic patients with acute coronary syndromes (2004) (0)
Neutrophil andeosinophil involvement ofthesmall bowelaffected bychronic alcoholism (1988) (0)
Serum eeosinophilic ccationic pprotein aand llactoferrin related tto ssmoking hhistory aand llung ffunction (1994) (0)
Investigation of neutrophil function in infection prone patients (1985) (0)
COVID-19 Antibody Testing of Patients Admitted to the ICU by a Novel, Point-of-Care Assay, and the Relationship to Survival (2021) (0)
Selected abstracts from allergy (2004) (0)
Screening for Proteinuria: A Tool for Predicting Rapid Declines in Kidney Function? (2011) (0)
65 RECEPTORS FOR PHAGOCYTOSIS AND ADHESION ON NEUTROPHIL GRANULOCYTES IN NEWBORN INFANTS (1994) (0)
[Does examination play any role in continuing education? Experiences from clinical chemistry]. (1993) (0)
90 Neutrophil and monocyte receptor expression in uncomplicated and complicated influenza A with pneumonia (2006) (0)
Selected abstracts from allergy (2004) (0)
Radioimmunoassay ofserummyoglobin in neuromuscular diseases (1981) (0)
Increased nitric oxide in expired air in patients with SjoÈ gren's syndrome (1999) (0)
Eosinophil and neutrophil granulocytes. Discussion (1993) (0)
A combination of pro-BNP och troponin T at baseline provide the best prediction of risk of death and myocardial infarction early after acute coronary syndrome (2003) (0)
Acute kidney injury - Human studies (2011) (0)
High dose NO increases primarily azurophil degranulation and reverses degranulation hierarchy (2005) (0)
HNL Dimer- A Specific Biomarker of Neutrophil Activity - In Sepsis and Antibiotics Monitoring. A Mini-Review (2022) (0)
The eosinophil and neutrophil granulocyte in asthma (1993) (0)
Effect of natural allergen avoidance on heath-labile chemotactic activities for eosinophils (HL-ECA) and eosinophil protein X (EPX) in allergic children (1991) (0)
Calprotectin, a new biomarker for diagnosis of acute respiratory infections (2020) (0)
Human Neutrophil Lipocalin (HNL) in the Distinction between Bacterial andViral Infections (2018) (0)
Advantage with heparin-coated cardiopulmonary devices. A clinical study (1994) (0)
In Honour of Paul Kallós (1987) (0)
Early risk stratification in ST-elevation myocardial infarction with admission Troponin T and ST-segment resolution (2002) (0)
Research | Environmental Medicine (2005) (0)
Markers of eosinophilic inflammation in allergic diseases. Discussion (1993) (0)
NO enhances basophil degranulation whereas antithrombin is primary inhibitor of FXIIa during inflammatory reaction (2005) (0)
Effects of high altitude on eosinophil protein X (EPX) serum levels and specific IgE for pteronyssinus (Dpt) and farinae (Df) in asthmatic children (1991) (0)
Monitoring of inflammation in relation to pathophysiology. Discussion (1993) (0)
[The mystery of eosinophil granulocytes--a 100 year jubilee]. (1979) (0)
Contents, Vol. 82, 1987 (1987) (0)
Cow's milk protein sensitivity is occuring frequently in coeliac disease (2005) (0)
Diagnostic procedure to detect the molecular forms of eosinophilic cationic protein (iso-ECPS). (1997) (0)
Schizophrenia and granulocyte function (1985) (0)
Calprotectin, a promising biomarker for diagnosis of respiratory tract infections (2019) (0)
824 Radioimmunoassay of human eosinophil protein X (EPX/EDN). Establishment of normal levels to serum and plasma and turnover in vivo (1991) (0)
C5a receptor expression and impaired chemotaxis in granulocytes from septic patients and from healthy subjects after exposure to C5a and interleukin-8 ex vivo (2005) (0)
[Specialist examination in clinical chemistry. Voluntary examination for higher competence]. (1993) (0)
Identification of Polymorphisms in the ECP - gene. Relation to disease activity in Hodgkin Lymphoma (2002) (0)
Cow's milk protein and gluten-enviromental factors to be considered in the pathogenesis of spondyloarthropathies (2009) (0)
Use of High-Sensitive cTn Assays for the Evaluation of Patients Potentially at Risk for Cardiovascular Disease (2016) (0)
An important risk indicator in unstable coronary artery disease. (1996) (0)
Exhaled NO but not eosinophilic inflammation is reduced by inhaled corticosteroid treatment in COPD (2013) (0)
PL-010 A radioimmunoassay (RIA) for human phospholipase B-precursor (PLB-P), a biological marker for neutrophil activities (2009) (0)
The coding ECP 434(GgC) polymorphism determines the cytotoxicity of ECP byt does not affect fibroblast-mediated gel contraction or RNase activity (2007) (0)
Subject Index, Vol. 29, 1981 (1981) (0)
Analyses of N-Terminal roB-Type Natriuretic Peptide n Patients With Non – ST-Segment levation Acute Coronary Syndromes Fragmin and Fast Revascularisation During nstability in Coronary Artery Disease ( FRISC )-II Substudy (2016) (0)
[Prognosis in unstable coronary artery disease. Multimarker strategy is the best basis for the therapeutic choice]. (2004) (0)
Diagnostic method for detecting isoforms of eosinophil cationic protein (1997) (0)
Using cardiac biomarkers to detect myocardial damage before the onset of CHD symptoms (2006) (0)
Impact of Peri-Stent Remodeling on In-Stent Neointimal Proliferation in Acute Myocardial Infarction (2004) (0)
Contents, Vol. 32, 1982 (1982) (0)
Eosinophil Proteins: Eosinophil granule proteins as markers of eosinophil activity in vivo (2000) (0)
Markers of the allergic inflammation (1995) (0)
Preface (1993) (0)
Sputum eosinophilia identifies systemic corticosteroid responsiveness in acute exacerbations of COPD (2011) (0)
572 High-Sensitive Troponin T and I as Markers of Disease Severity and Mortality Patients with Left-Ventricular Dysfunction or Pulmonary Hypertension (2011) (0)
Effect of Immunotherapy on Humoral and Cellular Markers in Allergic Patients (1995) (0)
Phagocyte Activation in Preterm Infants (1999) (0)
Airway hyperresponsiveness, peak flow variability and inflammatory markers in non‐asthmatic subjects with respiratory infections (2007) (0)
An Extragranular Compartment of Blood Eosinophils Contains Eosinophil Protein X/Eosinophil-Derived Neurotoxin (EPX/EDN) (2012) (0)
Processed during Secretion Eosinophil Cationic Protein (ECP) Is (2009) (0)
Mortality and pathophysiology of acute kidney injury according to time of occurrence in acute heart failure (2020) (0)
Beta-thromboglobulin in inflammatory synovial fluid (1983) (0)
Effects of high altitude on eosinophil cationic protein serum levels in asthmatic allergic children (1990) (0)
Serum concentrations of Thymidine kinase 1 measured using a novel antibody-based assay in patients with Hodgkin Lymphoma (2021) (0)
Contents, Vol. 29, 1981 (1981) (0)
A double-blind randomised control trial of peripheral blood eosinophils to direct prednisolone use in COPD exacerbations (2011) (0)
Priming of the Eosinophil Granulocyte in Asthma (1993) (0)
INCREASED PULMONARY GRANULOCYTE ACTIVATION IN PATENT DUCTUS ARTERIOSUS IN PREMATURE INFANTS (1994) (0)
[Current aspects of asthma]. (1993) (0)
Improving the quality of care in cardiac surgery — the role of the 'mortality' meeting (2011) (0)
AB0037 NEUTROPHIL GRANULOCYTES ARE PRIMED IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS (JIA) (2019) (0)
Growth Differentiation Factor 15 for Risk Stratification and Selection of an Invasive Treatment Strategy in Non–ST-Elevation Acute Coronary Syndrome Coronary Heart Disease (2007) (0)
[How to manage quality assurance at laboratories? A specialist's examination is necessary in the specialty of clinical chemistry]. (1995) (0)
EOSINOPHILS AND SERUM EOSINOPHILIC CATIONIC PROTEINS IN INTERLEUKIN‐2‐BASED IMMUNOTHERAPY FOR CANCER (1998) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Per Venge?

Per Venge is affiliated with the following schools:

Per Venge's Academic­Influence.com Rankings

Why Is Per Venge Influential?

Per Venge's Published Works

Published Works

What Schools Are Affiliated With Per Venge?

Per Venge's AcademicInfluence.com Rankings